Radiopharmaceutical pylarify FSS BPA
Active Awarded Last action
- Contract number
- 36C25026A0002
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 10
Veterans Health Administration, Department of Veterans Affairs
- Task orders
- 1 $1,082,616 obligated
Award facts
- Opportunity
-
- 36C25025Q0870 Solicitation number
- Combined order value
- $1,082,616 Current and potential, with all options
- Last date to order 21% complete
- IDV ceiling 20% used
- $5,413,080.00
- Maximum order
- $1,082,616.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
Veterans Integrated Service Network 10 awarded a Blanket Purchase Agreement to Progenics Pharmaceuticals Inc. on October 1, 2025, with a ceiling value of $5,413,080 and ultimate completion date of September 30, 2030, for supply of the radiopharmaceutical PYLARIFY (piflufolastat F-18) under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB).
PYLARIFY is a diagnostic imaging agent used in positron emission tomography scans to detect and localize prostate cancer. Progenics, a division of Lantheus Medical Imaging, Inc., is the sole manufacturer of this product for federal use. Performance occurs at North Billerica, Massachusetts.
The first BPA call under this agreement, awarded October 1, 2025, carries a ceiling of $1,082,616 and covers base-year delivery through September 30, 2026, at firm fixed price with no set-aside designation. The parent GSA Schedule contract, held by Lantheus Holdings, Inc., carries a ceiling of approximately $592.78 million and extends through March 2030, serving as the master vehicle for delivery orders across multiple Veterans Integrated Service Networks and the Defense Health Agency.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Radiopharmaceutical pylarify FSS BPA - base year delivery order | Veterans Integrated Service Network 10 (VHA) | $1,082,616 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36C25026A0002?
36C25026A0002 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 10 (Veterans Health Administration) on October 1, 2025.
How much is contract 36C25026A0002 worth?
Orders under 36C25026A0002 have obligated $1,082,616. 36C25026A0002's own ceiling is $5,413,080. A single order can be worth up to $1,082,616.
How many orders have been placed under contract 36C25026A0002?
1 order has been placed under 36C25026A0002, the latest on October 1, 2025.
Who can order from contract 36C25026A0002?
36C25026A0002 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 36C25026A0002 under another contract?
Yes. 36C25026A0002 is a blanket purchase agreement under 36F79725D0093, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25026A0002 competed?
The extent of competition for 36C25026A0002 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV